^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

dendritic cell activation therapy

Associations
Trials
Company:
SBI Biotech
Drug class:
Immunomodulator
Related drugs:
Associations
Trials
almost4years
Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis. (PubMed, Invest New Drugs)
Besides, ten related drugs that may have therapeutic effects on melanoma were also screened. These newly discovered genes and drugs provide new ideas for further research on melanoma.
Journal
|
FGF2 (Fibroblast Growth Factor 2) • ESRP1 (Epithelial Splicing Regulatory Protein 1) • CDH3 (Cadherin 3) • ZEB1 (Zinc Finger E-box Binding Homeobox 1)
|
dendritic cell activation therapy
almost4years
Interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis. (PubMed, Medicine (Baltimore))
IFI16 is overexpressed in RCC and may be an important oncogene in the progression of kidney. In addition, IFI16 may a marker for RCC diagnosis and prognosis, which may be related to immune infiltration.
Journal
|
IFI16 (Interferon Gamma Inducible Protein 16)
|
dendritic cell activation therapy
almost4years
Development of a prognostic model of glioma based on immune-related genes. (PubMed, Oncol Lett)
The infiltration of B cells, CD8 T cells, dendritic cells, macrophages and neutrophils was positively associated with the prognostic risk score. In the present study, several clinically significant survival-associated IRGs were identified, and a prognosis evaluation model of glioma was established.
Journal • IO biomarker
|
IDH1 (Isocitrate dehydrogenase (NADP(+)) 1) • CD8 (cluster of differentiation 8) • CDK4 (Cyclin-dependent kinase 4) • BIRC5 (Baculoviral IAP repeat containing 5) • SOCS1 (Suppressor Of Cytokine Signaling 1) • FCER1G (Fc Fragment Of IgE Receptor Ig)
|
dendritic cell activation therapy
almost4years
AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma. (PubMed, Front Oncol)
In addition, AUNIP expression was correlated with immune infiltration in various other tumors. In conclusion, AUNIP, which is associated with tumor immune infiltration, is a candidate diagnostic and prognostic biomarker for HCC and LUAD.
Journal
|
CD8 (cluster of differentiation 8)
|
dendritic cell activation therapy
almost4years
Phosphatase and Tensin Homolog Mutation in Immune Cell Infiltration and Clinicopathological Features of Low-Grade Gliomas. (PubMed, Front Mol Biosci)
In this study, we outlined an approach to assess the influence of PTEN mutations on prognosis, overall survival, and messenger RNA (mRNA) expression. Our results provided alternative strategies for the personalized treatment of patients with LGGs harboring the PTEN mutation.
Clinical • Journal
|
PTEN (Phosphatase and tensin homolog) • CD8 (cluster of differentiation 8)
|
PTEN mutation • PTEN expression
|
dendritic cell activation therapy
almost4years
FCGR1A Serves as a Novel Biomarker and Correlates With Immune Infiltration in Four Cancer Types. (PubMed, Front Mol Biosci)
FCGR1A may be a potential prognostic biomarker and related to immune infiltration levels in diverse cancers, especially in CESC, CHOL, KIRC, and SKCM. Besides, FCGR1A may be involved in the activation, regulation, or induction of immune cells and diverse physiological and pathological processes.
Journal
|
CD8 (cluster of differentiation 8) • FCGR3A (Fc Fragment Of IgG Receptor IIIa)
|
dendritic cell activation therapy
almost4years
RNF183 Is a Prognostic Biomarker and Correlates With Tumor Purity, Immune Infiltrates in Uterine Corpus Endometrial Carcinoma. (PubMed, Front Genet)
Besides, the expression of RNF183 in UCEC is significantly correlated with the expression of several immune cell markers, including B cell, M1 macrophage marker, M2 Macrophage, Dendritic cell, Th1 markers, Th2 markers, Treg markers, and T cell exhaustion markers, indicating its role in regulating tumor immunity. These results suggested that RNF183 may be considered as a novel prognostic factor in endometrial cancer and an early diagnostic indicator for patients with UCEC.
Journal
|
TP53 (Tumor protein P53)
|
TP53 mutation • ER positive
|
dendritic cell activation therapy
almost4years
Exogenous interleukin-33 promotes hepatocellular carcinoma growth by remodelling the tumour microenvironment. (PubMed, J Transl Med)
Taken together, IL-33 may be a key tumour promoter of HCC proliferation and tumourigenicity, an important mediator, and a potential therapeutic target for regulating HCC progression.
Journal
|
CD8 (cluster of differentiation 8)
|
dendritic cell activation therapy
4years
Immune Cell Confrontation in the Papillary Thyroid Carcinoma Microenvironment. (PubMed, Front Endocrinol (Lausanne))
During the occurrence and development of PTC, the overall immune level was increased, and the abundance and proportion of tumor-promoting immune cells were significantly increased, indicating that immune escape had been aggravated. Finally, we speculate that EBV may play an important role in changing the immune microenvironment of PTC tumors.
Journal
|
BRAF (B-raf proto-oncogene) • CD8 (cluster of differentiation 8)
|
BRAF mutation
|
dendritic cell activation therapy
4years
Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer. (PubMed, Int Immunopharmacol)
Our results suggest that DRP1 is a marker of poor prognosis in patients with BC and plays an important role in tumor-related immune infiltration.
Journal
|
CD8 (cluster of differentiation 8)
|
dendritic cell activation therapy
4years
Mining Database for the Clinical Significance and Prognostic Value of ESRP1 in Cutaneous Malignant Melanoma. (PubMed, Biomed Res Int)
Furthermore, our results suggested that ESRP1 played an important role in regulating tumor-associated macrophage polarization, dendritic cell infiltration, Treg cells, and T cell exhaustion. Our study demonstrates ESRP1 expression, prognostic value, and potential regulatory networks in CMM, thereby shedding light on the clinical significance of ESRP1, and provides a novel biomarker for determining prognosis and immune infiltration in CMM.
Clinical • Journal
|
ESRP1 (Epithelial Splicing Regulatory Protein 1)
|
ER expression
|
dendritic cell activation therapy
4years
Regulatory T Cells and Plasmacytoid Dendritic Cells Within the Tumor Microenvironment in Gastric Cancer Are Correlated With Gastric Microbiota Dysbiosis: A Preliminary Study. (PubMed, Front Immunol)
With pearson's correlation analysis, we found that several non-abundant genera such as Stenotrophomonas and Selenomonas were positively correlated with BDCA2pDCs and Foxp3Tregs, respectively, while Comamonas and Gaiella were negatively correlated with BDCA2pDCs and Foxp3 Tregs, respectively. The increased BDCA2pDCs and Foxp3Tregs might be modulated by gastric mucosal microbiota, both participated in the immunosuppression microenvironment of GC, which might provide evidence to establish new strategies in antitumor therapy targeting on gastric microbiota.
Journal
|
FOXP3 (Forkhead Box P3)
|
dendritic cell activation therapy
over4years
An Analysis Regarding the Association Between the ISLR Gene and Gastric Carcinogenesis. (PubMed, Front Genet)
ISLR expression was negatively correlated with sensitivity to PX-12 and NSC632839. Taken together, these results show that the ISLR gene is involved in gastric carcinogenesis, and the underlying molecular mechanisms may include DNA methylation, EMT, and immune cell infiltration.
Journal
|
CD8 (cluster of differentiation 8) • CDH1 (Cadherin 1) • COL1A1 (Collagen Type I Alpha 1 Chain)
|
dendritic cell activation therapy
over4years
Identification of miRNA-mRNA Regulatory Network and Construction of Prognostic Signature in Cervical Cancer. (PubMed, DNA Cell Biol)
The risk score of the prognostic model was also found to be associated with immune cells infiltration, including mast cell activation, natural killer cells resting, dendritic cells resting, T cells regulatory (Tregs), and T cells follicular helper. The miRNA-mRNA regulatory network and the prognostic model are of great clinical significance in promoting prognosis prediction and treatment of CC.
Journal
|
CXCL8 (Chemokine (C-X-C motif) ligand 8)
|
dendritic cell activation therapy
over4years
Integrated analysis of lymphocyte infiltration-associated lncRNA for ovarian cancer via TCGA, GTEx and GEO datasets. (PubMed, PeerJ)
On the other hand, FTX and LINC00665, which may play their possible roles through the ceRNA axis, demonstrated a potential to inhibit Tregs and prevent T-cell exhaustion. We defined several prognostic biomarkers for the incidence and progression of HGSOC and constructed a network for ceRNA axes; among which three were indicated to have a positive correlation with lymphocyte infiltration, namely: FTX-hsa-miR-150-5p-STK11, LINC00665-hsa-miR449b-5p-VAV3 and LINC00665-hsa-miR449b-5p-RRAGD.
Journal
|
STK11 (Serine/threonine kinase 11)
|
dendritic cell activation therapy
almost5years
Identification of Key Genes and Signaling Pathways Associated with the Progression of Gastric Cancer. (PubMed, Pathol Oncol Res)
APOE demonstrated the highest correlation with CD8 T cells, neutrophils, and dendritic cells whereas BGN had the highest correlation with macrophages. This study systematically explored the key genes and pathways involved in PGC and AGC, providing insights into therapeutic individualized management.
Journal
|
CD8 (cluster of differentiation 8) • TIMP1 (Tissue inhibitor of metalloproteinases 1) • COL1A1 (Collagen Type I Alpha 1 Chain)
|
dendritic cell activation therapy